Hospira to buy manufacturing facility in India
Aug 29 (Reuters) - Injectable generic drugs maker Hospira Inc said it plans to buy a factory and a research center from India-based Orchid Chemicals & Pharmaceuticals Ltd for $200 million.
Original Article: Hospira to buy manufacturing facility in India
NEXT ARTICLE